# Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma

Source: https://onco.cc/trials/nct01086488/  
OnCo record `nct01086488` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Temoporfin in Nasopharyngeal carcinoma, run by Ministry of Health, Malaysia, with a status the registry has not verified recently.

## Summary

Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma is a phase 2 interventional study registered as NCT01086488 by Ministry of Health, Malaysia, with 66 participants planned, started 2009-01 and due to reach its primary completion in 2011-09. Interventions recorded: FOSCAN. Conditions recorded: Nasopharyngeal Carcinoma.

Linked to the drug Temoporfin because the registry names it among its interventions and Nasopharyngeal carcinoma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01086488
- Phase: 2
- Setting: A Phase II, Randomized Controlled Trial of Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Recurrent or Persistent Nasopharyngeal Carcinoma
- Sponsor: Ministry of Health, Malaysia
- Enrolled: 66

## Sources

- ClinicalTrials.gov NCT01086488: https://clinicaltrials.gov/study/NCT01086488

## Connected records

- cancers: [Nasopharyngeal carcinoma](https://onco.cc/cancers/nasopharyngeal/)
- drugs: [Temoporfin](https://onco.cc/drugs/temoporfin/)

---
JSON: https://onco.cc/api/v1/entities/nct01086488.json